US Drug Recall Register
Class III · Low risk Terminated Initiated Jan 11, 2013 (14 years ago)

PULMICORT RESPULES 0.25 mg/2 ml Budesonide Inhalation Suspension

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.

What was recalled

PULMICORT RESPULES 0.25 mg/2 ml Budesonide Inhalation Suspension (30 ampules/carton) NDC: 0186-1988-04

Recalling firm
AstraZeneca LP
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-198-2013

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Budesonide recalls

See all
Class II · Moderate risk Ongoing

Budesonide Inhalation Suspension

Reason Presence of Foreign Substance:This recall has been initiated in response to a product quality complaint reported for black/brown specs and particles within the ampoule solution

Sun Pharmaceutical Industries INC NDC 47335-633-49 D-0607-2026
Class II · Moderate risk Ongoing

Budesonide Inhalation Suspension

Reason Lack of Assurance of Sterility: A market complaint was received for leakage and empty ampoule.

Cipla USA, Inc. NDC 69097-319-86 D-0541-2025
Class II · Moderate risk Ongoing

Airsupra

Reason Defective delivery system

AsttraZeneca Pharmaceuticals LP NDC 0310-9080-12 D-0444-2025
Class II · Moderate risk Completed

Budesonide

Reason CGMP Deviations and Presence of Particulate Matter: Glass

Medisca Inc. D-0570-2024
Class II · Moderate risk Terminated

Budesonide Extended-Release Tablets

Reason Failed Dissolution Specifications

Golden State Medical Supply Inc. NDC 51407-824-30 D-0276-2024